Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 1, 2017
Previous Article Next Article

A data-driven strategy for predicting greenness scores, rationally comparing synthetic routes and benchmarking PMI outcomes for the synthesis of molecules in the pharmaceutical industry

Author affiliations

Abstract

Cumulative Process Mass Intensity (PMI) is one of the most popular greenness metrics tracked during the lifecycle of a pharmaceutical compound. Its use is wide-spread, having come to represent the foundation of many assessments of efficiency. These metrics are critical during the development of a compound as analysis of efficiency data (such as PMI outcomes) can help minimize the environmental impact of pharmaceutical manufacturing, highlight areas for potential improvement and thus drive sustainability. However, there are several issues with many of the current metrics, one of the most pressing being the absence of such information when key synthetic strategy decisions are made in early development; many metrics articulate the impact of strategy decisions made in the absence of efficiency data. In this article, we develop a predictive analytics framework, coupled to Monte Carlo simulation, to address this issue and enable a rich understanding of potential PMI outcomes during both the decision making process (prediction) and the outcome review process (comparison). This method leverages real-world data to predict probable PMI ranges for a potential synthesis being considered, utilizing accumulated data which spans a range of molecules and phases of development. The approach can serve two critical functions lacking in current methods: (1) it can act as a decision-aiding tool during the route discovery process, predicting probable PMI outcomes for proposed, potential or unoptimized synthetic routes; (2) it can enable the direct comparison of the PMI outcome of a synthesis to all comparable chemistry, thus providing a benchmarking methodology capable of comparing PMIs across molecules. We envision that this approach will deliver significant impact to the green chemistry community by enabling greener decisions to be made at critical phases of invention, namely the ideation, route selection and development processes (designing green), along with providing a rational method to compare a specific outcome to prior art (benchmarking).

Graphical abstract: A data-driven strategy for predicting greenness scores, rationally comparing synthetic routes and benchmarking PMI outcomes for the synthesis of molecules in the pharmaceutical industry

Back to tab navigation

Supplementary files

Article information


Submitted
23 Aug 2016
Accepted
25 Oct 2016
First published
25 Oct 2016

Green Chem., 2017,19, 127-139
Article type
Paper

A data-driven strategy for predicting greenness scores, rationally comparing synthetic routes and benchmarking PMI outcomes for the synthesis of molecules in the pharmaceutical industry

J. Li, E. M. Simmons and M. D. Eastgate, Green Chem., 2017, 19, 127
DOI: 10.1039/C6GC02359B

Social activity

Search articles by author

Spotlight

Advertisements